Lv4
460 积分 2024-10-31 加入
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
1天前
已完结
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
1天前
已完结
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
1天前
已完结
Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook
1天前
已完结
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
1天前
已完结
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
1天前
已完结
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
1天前
已完结
Lung cancer immunotherapy: progress, pitfalls, and promises
1天前
已完结
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
4天前
已完结
Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer
4天前
已完结
皖公网安备34019202002308
